34.17

3.20% -1.13

After Hours: 34.17

Structure Therapeutics Inc Adr (GPCR)

Overview News Price History Option Chain Financials Why GPCR Down? Discussions Forecast

Structure Therapeutics Inc Adr stock is traded at $34.17, with a volume of 1.08M. It is down -3.20% in the last 24 hours and up +29.48% over the past month. Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Previous Close:

$35.30

Open:

$35.41

24h Volume:

1.08M

Relative Volume:

0.99

Market Cap:

$1.97B

Revenue:

Net Income/Loss:

$-100.44M

P/E Ratio:

-15.39

EPS:

-2.22

Net Cash Flow:

$-105.32M

1W Performance:

-0.96%

1M Performance:

+29.48%

6M Performance:

+39.19%

1Y Performance:

+0.47%

1-Day Range:

$33.95

$35.41

1-Week Range:

$33.36

$40.29

52-Week Range:

$13.22

$40.29

Structure Therapeutics Inc Adr Stock (GPCR) Company Profile

Name

Structure Therapeutics Inc Adr

Sector

Healthcare (1134)

Industry

Biotechnology (635)

Phone

(650) 457-1978

Address

601 GATEWAY BLVD SUITE 900, SOUTH SAN FRANCISCO

Employee

218

Twitter

Next Earnings Date

Latest SEC Filings

GPCR's Discussions on Twitter

Compare GPCR with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
GPCR Structure Therapeutics Inc Adr	34.17	2.14B	0	-100.44M	-105.32M	-2.22
VRTX Vertex Pharmaceuticals Inc	429.82	107.58B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	787.32	80.03B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	429.80	57.37B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	917.93	55.83B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	209.02	44.13B	447.02M	-1.18B	-906.14M	-6.1812

Structure Therapeutics Inc Adr Stock (GPCR) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-02-25	Initiated	Citigroup	Buy
Feb-28-25	Initiated	William Blair	Outperform
Jan-08-25	Initiated	Stifel	Buy
Dec-04-24	Initiated	H.C. Wainwright	Buy
Sep-23-24	Initiated	Morgan Stanley	Overweight
May-21-24	Initiated	JP Morgan	Overweight
Apr-09-24	Initiated	Cantor Fitzgerald	Overweight
Oct-19-23	Initiated	JMP Securities	Mkt Outperform
Jul-27-23	Initiated	Piper Sandler	Overweight
May-25-23	Resumed	Jefferies	Buy
Feb-28-23	Initiated	BMO Capital Markets	Outperform
Feb-28-23	Initiated	Guggenheim	Buy
Feb-28-23	Initiated	Jefferies	Buy
Feb-28-23	Initiated	SVB Securities	Outperform

View All

Structure Therapeutics Inc Adr Stock (GPCR) Latest News

Nov 24, 2025

Buy Rating for Structure Therapeutics, Inc.: Potential Disruption in Obesity Treatment with Amylin Agonists - TipRanks

Nov 24, 2025

Nov 20, 2025

Structure Therapeutics Reports Q3 2025 Financial Results - MSN

Nov 20, 2025

Buy Rating on Structure Therapeutics, Inc. Driven by Aleniglipron’s Potential in the Obesity Market - TipRanks

Nov 20, 2025

Nov 19, 2025

Avago, Google among market cap stock movers on Wednesday By Investing.com - Investing.com South Africa

Nov 19, 2025

Avago, Google among market cap stock movers on Wednesday - Investing.com

Nov 19, 2025